These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 17464147

  • 1. Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock.
    Hirasawa H, Oda S, Matsuda K.
    Contrib Nephrol; 2007; 156():365-70. PubMed ID: 17464147
    [Abstract] [Full Text] [Related]

  • 2. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.
    Nakamura M, Oda S, Sadahiro T, Hirayama Y, Watanabe E, Tateishi Y, Nakada TA, Hirasawa H.
    Contrib Nephrol; 2010; 166():73-82. PubMed ID: 20472994
    [Abstract] [Full Text] [Related]

  • 3. Treatment of septic shock with continuous HDF using 2 PMMA hemofilters for enhanced intensity.
    Matsumura Y, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Abe R, Nakada TA, Tateishi Y, Oshima T, Shinozaki K, Hirasawa H.
    Int J Artif Organs; 2012 Jan; 35(1):3-14. PubMed ID: 22287204
    [Abstract] [Full Text] [Related]

  • 4. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis.
    Hirasawa H, Oda S, Nakamura M, Watanabe E, Shiga H, Matsuda K.
    Blood Purif; 2012 Jan; 34(2):164-70. PubMed ID: 23095416
    [Abstract] [Full Text] [Related]

  • 5. Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock.
    Nakada TA, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R, Hirasawa H.
    Mol Med; 2008 Jan; 14(5-6):257-63. PubMed ID: 18327291
    [Abstract] [Full Text] [Related]

  • 6. Continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter for severe acute pancreatitis.
    Abe R, Oda S, Shinozaki K, Hirasawa H.
    Contrib Nephrol; 2010 Jan; 166():54-63. PubMed ID: 20472992
    [Abstract] [Full Text] [Related]

  • 7. Comparison of efficacy between continuous hemodiafiltration with a PMMA high-performance membrane dialyzer and a PAN membrane hemofilter in the treatment of septic shock patients with acute renal failure.
    Matsuda K, Moriguchi T, Harii N, Yanagisawa M, Harada D, Sugawara H.
    Contrib Nephrol; 2011 Jan; 173():182-190. PubMed ID: 21865791
    [Abstract] [Full Text] [Related]

  • 8. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report.
    Shiga H, Hirasawa H, Nishida O, Oda S, Nakamura M, Mashiko K, Matsuda K, Kitamura N, Kikuchi Y, Fuke N.
    Blood Purif; 2014 Jan; 38(3-4):211-8. PubMed ID: 25531978
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter after polymyxin B-immobilized fiber column therapy of septic shock.
    Sakamoto Y, Mashiko K, Obata T, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y.
    ASAIO J; 2008 Jan; 54(1):129-32. PubMed ID: 18204329
    [Abstract] [Full Text] [Related]

  • 13. The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF).
    Nakamura M, Oda S, Sadahiro T, Hirayama Y, Tateishi Y, Abe R, Hirasawa H.
    Transfus Apher Sci; 2009 Feb; 40(1):41-7. PubMed ID: 19109071
    [Abstract] [Full Text] [Related]

  • 14. [Indications for and clinical efficacy of continuous hemodiafiltration (CHDF) for severe acute pancreatitis].
    Hirasawa H, Oda S, Shiga H, Matsuda K, Abe R.
    Nihon Rinsho; 2004 Nov; 62(11):2094-100. PubMed ID: 15552894
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Continuous hemodiafiltration in the treatment of reactive hemophagocytic syndrome refractory to medical therapy.
    Tateishi Y, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Abe R, Hirasawa H.
    Transfus Apher Sci; 2009 Feb; 40(1):33-40. PubMed ID: 19097821
    [Abstract] [Full Text] [Related]

  • 17. [Endotoxin removal in septic shock].
    Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K, Nakamura M.
    Nihon Geka Gakkai Zasshi; 2002 Dec; 103(12):880-6. PubMed ID: 12599928
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Non-renal indications for continuous renal replacement therapy: current status in Japan.
    Oda S, Sadahiro T, Hirayama Y, Nakamura M, Watanabe E, Tateishi Y, Hirasawa H.
    Contrib Nephrol; 2010 Dec; 166():47-53. PubMed ID: 20472991
    [Abstract] [Full Text] [Related]

  • 20. Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis.
    Nishida O, Nakamura T, Kuriyama N, Hara Y, Yumoto M, Shimomura Y, Moriyama K.
    Contrib Nephrol; 2011 Dec; 173():172-181. PubMed ID: 21865790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.